Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Promoting the accumulation of tumor-specific T cells in tumor tissues by dendritic cell vaccines and chemokine-modulating agents
Authors
Keywords
-
Journal
Nature Protocols
Volume 13, Issue 2, Pages 335-357
Publisher
Springer Nature
Online
2018-01-19
DOI
10.1038/nprot.2017.130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
- (2016) Haidong Tang et al. CANCER CELL
- Driving gene-engineered T cell immunotherapy of cancer
- (2016) Laura A Johnson et al. CELL RESEARCH
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional reprogramming of human prostate cancer to promote local attraction of effector CD8+T cells
- (2016) Ravikumar Muthuswamy et al. PROSTATE
- Modulation of chemokines in the tumor microenvironment enhances oncolytic virotherapy for colorectal cancer
- (2016) Lily Francis et al. Oncotarget
- Synergistic COX2 Induction by IFN and TNF Self-Limits Type-1 Immunity in the Human Tumor Microenvironment
- (2016) J. L. Wong et al. Cancer Immunology Research
- Prolonged intralymphatic delivery of dendritic cells through implantable lymphatic ports in patients with advanced cancer
- (2016) Michal Radomski et al. Journal for ImmunoTherapy of Cancer
- Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer
- (2015) Stephanie Downs-Canner et al. ANNALS OF SURGICAL ONCOLOGY
- Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment
- (2015) Angela Vasaturo et al. IMMUNOBIOLOGY
- Toward improved effectiveness of bladder cancer immunotherapy
- (2015) Pawel Kalinski et al. Immunotherapy
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Next Hurdle in Cancer Immunotherapy: Overcoming the Non–T-Cell–Inflamed Tumor Microenvironment
- (2015) Thomas F. Gajewski SEMINARS IN ONCOLOGY
- Evolution of animal models in cancer vaccine development
- (2015) Wei-Zen Wei et al. VACCINE
- Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy
- (2015) Jashodeep Datta et al. Frontiers in Immunology
- Dendritic Cell-Based Vaccination in Cancer: Therapeutic Implications Emerging from Murine Models
- (2015) Soledad Mac Keon et al. Frontiers in Immunology
- CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
- (2015) Zuqiang Liu et al. OncoImmunology
- Consensus nomenclature for CD8+T cell phenotypes in cancer
- (2015) Lionel Apetoh et al. OncoImmunology
- Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction
- (2015) Ravikumar Muthuswamy et al. Journal for ImmunoTherapy of Cancer
- Adoptive Immunotherapy for Cancer or Viruses
- (2014) Marcela V. Maus et al. Annual Review of Immunology
- Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
- (2014) Xuanming Yang et al. CANCER CELL
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Clinical use of dendritic cells for cancer therapy
- (2014) Sébastien Anguille et al. LANCET ONCOLOGY
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
- (2014) Nicolas J. Llosa et al. Cancer Discovery
- STING Contributes to Antiglioma Immunity via Triggering Type I IFN Signals in the Tumor Microenvironment
- (2014) T. Ohkuri et al. Cancer Immunology Research
- The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy
- (2014) Jennifer A Westwood et al. OncoImmunology
- Trial watch: IDO inhibitors in cancer therapy
- (2014) Erika Vacchelli et al. OncoImmunology
- Targeting dendritic cells--why bother?
- (2013) M. Kreutz et al. BLOOD
- IL-18-Primed Helper NK Cells Collaborate with Dendritic Cells to Promote Recruitment of Effector CD8+ T Cells to the Tumor Microenvironment
- (2013) J. L. Wong et al. CANCER RESEARCH
- Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies
- (2013) Pawel Kalinski et al. Expert Review of Vaccines
- Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
- (2013) Michael Kalos et al. IMMUNITY
- IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity
- (2013) Beatriz M. Carreno et al. JOURNAL OF CLINICAL INVESTIGATION
- Oncolytic viruses as therapeutic cancer vaccines
- (2013) David L Bartlett et al. Molecular Cancer
- A Rationally Designed A34R Mutant Oncolytic Poxvirus: Improved Efficacy in Peritoneal Carcinomatosis
- (2013) Pragatheeshwar Thirunavukarasu et al. MOLECULAR THERAPY
- Tissues in Different Anatomical Sites Can Sculpt and Vary the Tumor Microenvironment to Affect Responses to Therapy
- (2013) Christel Devaud et al. MOLECULAR THERAPY
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy
- (2013) Christel Devaud et al. OncoImmunology
- IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients
- (2013) Jeffrey L. Wong et al. OncoImmunology
- Oncolytic Virus and Anti-4-1BB Combination Therapy Elicits Strong Antitumor Immunity against Established Cancer
- (2012) L. B. John et al. CANCER RESEARCH
- NF- B Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells
- (2012) R. Muthuswamy et al. CANCER RESEARCH
- Therapeutic Cancer Vaccines: Current Status and Moving Forward
- (2012) J. Schlom JNCI-Journal of the National Cancer Institute
- Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects
- (2012) Padma Sampath et al. MOLECULAR THERAPY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunobiology of human mucin 1 in a preclinical ovarian tumor model
- (2012) R A Budiu et al. ONCOGENE
- Type I interferon response and innate immune sensing of cancer
- (2012) Mercedes B. Fuertes et al. TRENDS IN IMMUNOLOGY
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
- (2011) Sally M. Amos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
- (2011) W. H. Fridman et al. CANCER RESEARCH
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
- (2011) M. Fujita et al. CANCER RESEARCH
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
- (2011) Sid P. Kerkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Antitumor Activity Mediated by CpG
- (2011) Yanyan Lou et al. JOURNAL OF IMMUNOTHERAPY
- PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
- (2011) Jacalyn Rosenblatt et al. JOURNAL OF IMMUNOTHERAPY
- Optimizing parameters for clinical-scale production of high IL-12 secreting dendritic cells pulsed with oxidized whole tumor cell lysate
- (2011) Cheryl L-L Chiang et al. Journal of Translational Medicine
- Defining the critical hurdles in cancer immunotherapy
- (2011) Bernard A Fox et al. Journal of Translational Medicine
- Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
- (2011) Ling Zhang et al. MOLECULAR THERAPY
- Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer
- (2011) Jun Li et al. MOLECULAR THERAPY
- Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells
- (2010) G. Schreibelt et al. BLOOD
- New flow cytometric assays for monitoring cell-mediated cytotoxicity
- (2010) Liubov Zaritskaya et al. Expert Review of Vaccines
- Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
- (2010) Hideho Okada et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
- (2010) Elizabeth D. Thompson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
- (2010) Konrad Wilhelm et al. NATURE MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Type-1 polarized dendritic cells loaded with apoptotic prostate cancer cells are potent inducers of CD8+ T cells against prostate cancer cells and defined prostate cancer-specific epitopes
- (2010) Eva Wieckowski et al. PROSTATE
- Signaling Through OX40 Enhances Antitumor Immunity
- (2010) Shawn M. Jensen et al. SEMINARS IN ONCOLOGY
- Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines
- (2009) Adam S. Giermasz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
- (2009) A. Ribas et al. CLINICAL CANCER RESEARCH
- Independent Regulation of Chemokine Responsiveness and Cytolytic Function versus CD8+ T Cell Expansion by Dendritic Cells
- (2009) P. B. Watchmaker et al. JOURNAL OF IMMUNOLOGY
- Development of a Potency Assay for Human Dendritic Cells: IL-12p70 Production
- (2009) Lisa H. Butterfield et al. JOURNAL OF IMMUNOTHERAPY
- Recruitment and Activation of Natural Killer Cells In vitro by a Human Dendritic Cell Vaccine
- (2008) K. Gustafsson et al. CANCER RESEARCH
- Using Dendritic Cell Maturation and IL-12 Producing Capacity as Markers of Function: A Cautionary Tale
- (2008) Anjum S. Kaka et al. JOURNAL OF IMMUNOTHERAPY
- Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia
- (2008) Je-Jung Lee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Abundant expression of CXCL9 (MIG) by stromal cells that include dendritic cells and accumulation of CXCR3+T cells in lymphocyte-rich gastric carcinoma
- (2008) H Ohtani et al. JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started